Back to Search

Melatonin for Treatment of Delirium in Critically Ill Adult Patients

Recruiting Phase 2 Interventional Study
Delirium
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
Ciusss de L'Est de l'Île de Montréal · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to determine the feasibility of conducting a randomized controlled trial (RCT) with melatonin for treatment of delirium in critically ill adult patients. From a feasibility perspective, the investigators believe that the proposed design will achieve the minimum enrollment rate necessary to conduct a future RCT on a larger scale.

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years or older admitted to the intensive care unit; * Anticipated ICU stay \> 48 hours; * ICDSC score greater than or equal to 4 for a maximum of 48 hours prior to randomization. Exclusion Criteria: * Known allergy or hypersensitivity to melatonin or to ingr…
Contacts

Johannie Beaucage-Charron, Pharm.D., M.Sc.

514 252 3400

johannie.beaucage-charron.cemtl@ssss.gouv.qc.ca

CONTACT

NCT ID: NCT05713877 Source: ClinicalTrials.gov